Stine Ydegaard Turiño

ORCID: 0000-0001-9725-2201
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Inflammatory Bowel Disease
  • Gallbladder and Bile Duct Disorders
  • Esophageal and GI Pathology
  • IL-33, ST2, and ILC Pathways
  • Inflammasome and immune disorders
  • Immune Response and Inflammation
  • Microscopic Colitis
  • Biliary and Gastrointestinal Fistulas
  • Whipple's Disease and Interleukins
  • Venous Thromboembolism Diagnosis and Management
  • Pediatric Hepatobiliary Diseases and Treatments
  • Atrial Fibrillation Management and Outcomes
  • Diagnosis and treatment of tuberculosis
  • Appendicitis Diagnosis and Management
  • Case Reports on Hematomas

Ospedali Riuniti San Giovanni di Dio e Ruggi d'Aragona
2023

Zealand University Hospital
2020

Bispebjerg Hospital
2014-2018

University of Copenhagen
2014-2018

Summary of Recommendations 1 ESGE recommends that each center implements a written policy regarding the management iatrogenic perforations, including definition procedures carry higher risk this complication. This should be shared with radiologists and surgeons at center. 2 in case an endoscopically identified perforation, endoscopist reports its size location, image, statement endoscopic treatment has been applied. 3 symptoms or signs suggestive perforation after procedure rapidly carefully...

10.1055/a-1222-3191 article EN Endoscopy 2020-08-11

Antitumor necrosis factor-α (TNF-α) is used for treatment of severe cases inflammatory bowel diseases (IBD), including Crohn's disease (CD) and ulcerative colitis (UC). However, one-third the patients do not respond to treatment. Genetic markers may predict individual response anti-TNF therapy. Using a candidate gene approach, 39 mainly functional single nucleotide polymorphisms (SNPs) in 26 genes regulating inflammation were assessed 738 prior anti-TNF-naive Danish with IBD. The results...

10.1038/tpj.2014.19 article EN cc-by-nc-sa The Pharmacogenomics Journal 2014-04-29

Background The inflammatory bowel diseases (IBD), Crohn's disease (CD) and ulcerative colitis (UC), result from the combined effects of susceptibility genes environmental factors. Polymorphisms in regulating inflammation may explain part genetic heritage. Methods Using a candidate gene approach, 39 mainly functional single nucleotide polymorphisms (SNPs) 26 were assessed clinical homogeneous group severely diseased patients consisting 624 with CD, 411 UC 795 controls. results analysed using...

10.1371/journal.pone.0098815 article EN cc-by PLoS ONE 2014-06-27

Background The inflammatory bowel diseases (IBD), Crohn’s disease (CD) and ulcerative colitis (UC), result from the combined effects of susceptibility genes environmental factors. Previous studies have shown that polymorphisms in Toll-like receptor (TLR), apoptosis, IL-23/IL-17 interferon gamma (IFNG) pathways are associated with risk both CD UC. Methods Using a candidate gene approach, 21 functional single nucleotide (SNPs) 15 were assessed clinical homogeneous group severely diseased...

10.1371/journal.pone.0145302 article EN cc-by PLoS ONE 2015-12-23

Dieses Positionspapier ist eine offizielle Stellungnahme der Europäischen Gesellschaft für Gastrointestinale Endoskopie (ESGE). Es behandelt die Diagnose und das Management iatrogener Perforationen, während diagnostischer therapeutischer Endoskopien entstehen. <b>Hauptempfehlungen</b>

10.1055/s-0034-1385256 article DE Endoskopie heute 2014-10-20

Abstract The introduction of more effective and powerful antithrombotic therapies has allowed the progressive reduction ischemic events associated however with an increase in haemorrhagic events. What we are describing is example how iatrogenic non–iatrogenic complications can add up, making routine therapeutic management difficult during after hospital stay.We talking about a 50–year–old male patient, smoker history dyslipidemia under treatment, who arrived at our cath–lab diagnosis...

10.1093/eurheartjsupp/suad111.289 article EN European Heart Journal Supplements 2023-05-01
Coming Soon ...